EMA Seeks Industry Feedback On New Scheme For Supporting Drugs For Unmet Needs
This article was originally published in SRA
Executive Summary
The European Medicines Agency is hosting a consultation meeting with industry stakeholders on Oct. 1 to gather feedback on the key features of a new scheme under which it intends to provide better procedural support to sponsors of innovative medicines that have the potential to address unmet medical needs1.